Regulations.gov document
Guidance for Industry; Availability: Enforcement Policy Regarding Investigational New Drug…
Notice · FDA-2013-D-0811 · posted Jul 18, 2013
Key facts
| Document ID | FDA-2013-D-0811-0001 |
|---|---|
| Title | Guidance for Industry; Availability: Enforcement Policy Regarding Investigational New Drug Requirements; Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies |
| Document type | Notice |
| Agency | FDA |
| Docket | FDA-2013-D-0811 |
| Posted | Jul 18, 2013 |
| FR document number | 2013-17223 |
| Comment period opens | Jul 18, 2013 |
At a glance
- 1–9 Pages
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: